| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 10/21/2004 | US20040209866 1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders |
| 10/21/2004 | US20040209856 Oral pharmaceutical products containing 17beta-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| 10/21/2004 | US20040209853 Orally active 7.alpha.-alkyl androgens |
| 10/21/2004 | US20040209824 administering a sulfamate compound (topiramate) to mammals |
| 10/21/2004 | US20040209817 Methods and compositions for the treatment of peripheral artery disease |
| 10/21/2004 | US20040209816 Treatment for diabetes |
| 10/21/2004 | US20040209798 biodrugs for treatment of lung cancer, glioma, anorexia, hypothyroidism, hyperaldosteronism, H. pylori proliferation, acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites |
| 10/21/2004 | CA2521879A1 Process for resolving amines that are useful for the treatment of disorders associated with insulin resistance syndrome |
| 10/20/2004 | EP1468092A2 Pim-3 kinase as a target for type 2 diabetes mellitus |
| 10/20/2004 | EP1468020A2 Multimers of receptor-binding ligands |
| 10/20/2004 | EP1467982A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof |
| 10/20/2004 | EP1467979A2 FUSED HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF: MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION |
| 10/20/2004 | EP1467976A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 10/20/2004 | EP1467974A1 Benzimidazole derivatives and their use as gnrh antagonists |
| 10/20/2004 | EP1467752A1 HUMAN MAST CELL−EXPRESSED MEMBRANE PROTEINS |
| 10/20/2004 | EP1467739A2 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 10/20/2004 | EP1467730A1 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof |
| 10/20/2004 | EP1467716A2 Polytartrate composition |
| 10/20/2004 | EP1467714A1 Drug mixture with enhanced dissolution rate |
| 10/20/2004 | EP1467705A2 Therapeutic agent delivery tampon |
| 10/20/2004 | EP1263725B1 Novel compounds |
| 10/20/2004 | EP1230236B1 Compound with growth hormone releasing properties |
| 10/20/2004 | EP1198477B1 Prolactin-releasing peptide and use in treating pain |
| 10/20/2004 | EP0830136B1 New cryptophycins from synthesis |
| 10/20/2004 | CN1538969A Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins |
| 10/20/2004 | CN1538956A Spiro compounds |
| 10/20/2004 | CN1538852A Mixtures of growth horomone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof and methods of making same |
| 10/20/2004 | CN1537541A Applicaton of montmorillonite inpreparing medicine |
| 10/20/2004 | CN1171888C Substituted purin derivatives, preparation method and use |
| 10/20/2004 | CN1171583C Medical percutaneous preparation containing hydrophilic or salt form |
| 10/19/2004 | USRE38629 Bioavailability; non-insulin depedent diabetes; hypoglycemic agents; treating metabolic disorders, impaired glucose tolerance, and insulin resistance |
| 10/19/2004 | US6806263 New 17 alpha -fluoroalkyl steroids of general formula i as antiestrogens |
| 10/19/2004 | US6806262 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds |
| 10/19/2004 | US6805861 Administering therapeutically effective amount of cytotoxic t lymphocytes which have different hla class i complex (or equivalent) than cells to be killed, and specifically recognize peptide portion of antigen presented on cell surface |
| 10/19/2004 | CA2139929C Transdermal therapeutic system containing the active substance 17-.beta.-oestradiol (anhydrous) |
| 10/14/2004 | WO2004087763A1 Modified antibody against cd22 and utilization thereof |
| 10/14/2004 | WO2004087644A1 Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof |
| 10/14/2004 | WO2004087182A1 Active ingredient combinations of plant oils containing $g(v)3-fatty acids and plant extracts containing isoprenoids and the use thereof |
| 10/14/2004 | WO2004087127A1 Synergistic hepatoprotective composition and a method thereof |
| 10/14/2004 | WO2004042076A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4a (pde4a) |
| 10/14/2004 | WO2004000785A3 Phenyloxyalkanonic acid derivatives as hppar activators |
| 10/14/2004 | WO2003075945A3 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis |
| 10/14/2004 | US20040204417 For therapy of cancer |
| 10/14/2004 | US20040204393 Aromatase inhibition to enhance assisted reproduction |
| 10/14/2004 | US20040204392 use of trilostane or a 3-enol C1-4 alkanoate ester thereof; treatment of Cushing's syndrome in humans and veterinary animals |
| 10/14/2004 | US20040204390 Pharmaceutical combination comprising an anti-androgen and an oestrogen receptor beta agonist |
| 10/14/2004 | US20040204368 Oxadiazole derivative compounds and drugs containing these compounds as the active ingredient |
| 10/14/2004 | US20040203111 UDP-N-acetylglucosamine: galactose-B1,3-N-acetylgalactosamine-a-R/ (GlcNAc to GalNAc) B1-6 N- acetylglucosaminyltransferase, C2GnT3 |
| 10/14/2004 | US20040203097 Kinases and phosphatases |
| 10/14/2004 | US20040203092 UDP-N-acetylglucosamine:galactose-beta1,3-N-acetylgalactosamine-alpha-R/ (GlcNAc to GalNAc) beta1-6 N-acetylglucosaminyltransferase, C2GnT3 |
| 10/14/2004 | US20040203054 Use of SLIM3 for binding to molecules |
| 10/14/2004 | US20040203014 Neurotransmisson-associated proteins |
| 10/14/2004 | US20040202736 Method of ameliorating side-effects of SERMs |
| 10/14/2004 | US20040202651 Uses of anti-insulin-like growth factor 1 receptor antibodies |
| 10/14/2004 | DE10315024A1 Wirkstoffkombination aus ω3-fettsäurehaltigen Ölen mit isoprenoidhaltigen Pflanzenextrakten und deren Verwendung Active ingredient combination of ω3-fatty acid-containing oils with isoprenoidhaltigen plant extracts and their use |
| 10/13/2004 | EP1466913A1 Benzoylecgonine, ecgonine and ecgonidine derivatives |
| 10/13/2004 | EP1466901A1 Serotonine reuptake inhibitor |
| 10/13/2004 | EP1466618A1 Treatment for diabetes |
| 10/13/2004 | EP1466009A2 Highly sensitive and continuous protein-tyrosine-phosphatase (ptpase) test using 6.8 difluoro-4-methyl-umbelliferylphosphate |
| 10/13/2004 | EP1465916A2 Novel g proein-coupled receptor, gave7 |
| 10/13/2004 | EP1465886A1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 10/13/2004 | EP1465880A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine |
| 10/13/2004 | EP1465649A2 Methods and compositions for derepression of iap-inhibited caspase |
| 10/13/2004 | EP1465638A2 Phosphate transport inhibitors |
| 10/13/2004 | EP1465619A1 Suppression of cartilage degradation via the estrogen receptor |
| 10/13/2004 | EP1465602A1 Matrix film tablets for the controlled release of natural mixtures of conjugated estrogen |
| 10/13/2004 | EP1280797B1 Inhibitors of dipeptidyl peptidase iv |
| 10/13/2004 | EP1169038A4 Cyclic protein tyrosine kinase inhibitors |
| 10/13/2004 | EP1131340B1 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 10/13/2004 | EP1086086B1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 10/13/2004 | CN1537019A Medical combination of aldosterone receptor antagonist and HMG CoA reductase inhibitor |
| 10/13/2004 | CN1537008A Pharmaceutical combination comprising either (S)-20ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl}ethoxy)phenyl] propanoic acid |
| 10/13/2004 | CN1537002A Novel theterocyclic analogs of diphenylethylene compounds |
| 10/13/2004 | CN1170819C Piperidine alcohols |
| 10/12/2004 | US6803480 Therapeutic treatment and/or prophylaxis of arteriosclerosis and hypercholesterolaemia |
| 10/12/2004 | US6803372 Such as cis-n-(4-benzoylphenyl)-4-hydroxy-3'-oxospiro (cyclohexane-1,1' (3'h)-isobenzofuran)-4-carboxamide for use as neuropeptide y receptor antagonist for treatment bulimia, obesity or diabetes |
| 10/12/2004 | US6803359 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs |
| 10/12/2004 | US6803199 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 10/07/2004 | WO2004084945A1 Eating controllers |
| 10/07/2004 | WO2003057725A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 10/07/2004 | US20040198980 Selective rxr ligands |
| 10/07/2004 | US20040198832 Compositions and methods for treating amyloidosis |
| 10/07/2004 | US20040198799 Methods of increasing endogenous testosterone levels |
| 10/07/2004 | US20040198791 Fused imidazole derivative |
| 10/07/2004 | US20040198781 Carbonic anhydrase inhibitor |
| 10/07/2004 | US20040198735 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 10/07/2004 | US20040198726 Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists |
| 10/07/2004 | US20040198717 4-(trifluoromethyl)-7,8,9,10-tetrahydrochromeno[7,6-b]azepin-2(6H)-one and derivatives;4-(trifluoromethyl)-1,6,7,8,9,10-hexahydro-2H-azepino[3,2-g]quinolin-2-one and derivatives; useful in the treating conditions caused by androgen deficiency such as bone disorders |
| 10/07/2004 | US20040198677 macrolide and steroidal or non-steroidal substructures connected by an alkyl linker; esterification or amidation to couple; antiarthritic, antiasthmatic agents, nasal, gastrointestinal, dermatological and opthalmic disorders; veterinary or human therapy |
| 10/07/2004 | US20040198674 Compositions for preventing hormone induced adverse effects |
| 10/07/2004 | US20040198671 Estrogenic component comprising estetrol and estetrol-like substances, which has relatively low estrogenic potency, metabolic stability, long half-life; triene steroids; osteoporosis, arteriosclerosis, cognitive disturbances, Alzheimer's disease, peri- or post-menopausal disorders |
| 10/07/2004 | US20040198670 Novel estrogenic compounds |
| 10/07/2004 | US20040198651 Secreted proteins |
| 10/07/2004 | US20040197827 Contacting with Ewing sarcoma protein and nuclear receptor; determining binding and changes in ligand-induced activity; use in diagnosis and treatment |
| 10/07/2004 | US20040197265 Methods and pharmaceuticals for treating muscle insulin resistance and related conditions |
| 10/06/2004 | EP1464650A2 Novel estrogenic compounds, obtainable by heat treatment of conjugated estrogens in high humidity |
| 10/06/2004 | EP1464337A1 Regulation of intracellular glucocorticoid concentrations |
| 10/06/2004 | EP1463801A2 Transdifferentiation of pancreatic acinar cells |
| 10/06/2004 | EP1463728A2 Fused cyclic modulators of nuclear hormone receptor function |
| 10/06/2004 | EP1463715A1 Novel glucagon antagonists |